Prognostic value of procalcitonin in infection-related mortality of cancer patients


Sedef A. M. , Kose F., Sumbul A. T. , Dogan O., Kursun E., Yurdakul Z., et al.

JOURNAL OF BUON, cilt.21, ss.740-744, 2016 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 21 Konu: 3
  • Basım Tarihi: 2016
  • Dergi Adı: JOURNAL OF BUON
  • Sayfa Sayısı: ss.740-744

Özet

Purpose: Infectious diseases are a major cause of morbidity and mortality in cancer patients. Tumor-induced inflammatory responses may increase the value of classical inflammatory markers in blood, so these markers may not be as useful in cancer patients as in non-cancer patients. Serum procalcitonin (PCT) is a sensitive and specific biomarker for severe infection, and has been shown to be unaffected by tumor-induced inflammatory response. In this study we aimed to evaluate the possible role of PCT in mortality in cancer patients with infection.